We read with interest the letter of Dr. Batsis regarding our *Surgical Endoscopy* article in which we assessed the clinical value of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for mediastinal lymph nodes in low-volume EUS centers \[[@CR1]\].

We fully agree with the author that EUS-FNA is an invasive method for staging and sampling mediastinal lymphadenopathy that may be associated with complications such as perforations. In addition, FNA is technically demanding, and it is not easy to determine which lymph node to puncture because current sonographic criteria for malignant lymph nodes lack specificity \[[@CR2]\]. However, EUS-FNA does seem to play a major role in determining the surgical approach \[[@CR3]\], and more important, seems to avoid futile surgical interventions in both low- and high-volume EUS centers \[[@CR1], [@CR4]\].

Indeed, it would be desirable to avoid such an invasive method, for instance, by measuring biomarkers in serum samples. However, we believe that these diagnostic options currently are not clinically available.

An interesting alternative that may avoid FNA, or at least decrease the number of ultrasound-guided punctures, is EUS elastography. This technique, a further development of the well-known breast ultrasound fremitus technique, is based on the fact that a change in tissue resulting in malignant, fibrotic, inflamed or normal tissue may alter elasticity \[[@CR5]\].

Instead of asking the patient to hum for vibration during color Doppler examination of the breast, for EUS tissue elasticity imaging, vibrations and compressions are provided physiologically by vascular pulsation and respiratory motion. The calculation of tissue elasticity distribution is performed in real time, and the elasticity results are presented in different colors projected over the conventional B-mode image, with malignant tissue appearing in blue, fibrosis in green, normal tissue in yellow, and fat in red \[[@CR6]\]. Unfortunately, only the Pentax EUS-scope (EG 38-UT; Pentax Europe Gmbh Hamburg, Germany) but not the Olympus EUS scope (GF-UCT140; Olympus, Hamburg, Germany) is equipped with this diagnostic tool.

Initial research focusing on breast cancer showed that tissue elastography correctly classifies benign and malignant tissue \[[@CR6]\]. The first results for lymph nodes evaluated with EUS elastography and verified with final cytology collected by EUS-FNA showed no false-negatives but five false-positives, resulting in a sensitivity of 100% and a specificity of 50% \[[@CR5]\].

The authors concluded that the disappointing specificity may improve rapidly with increasing experience and better-defined criteria. A larger study recently showed better diagnostic results with a sensitivity of 100%, a specificity of 83%, a negative predictive value of 100%, and a positive predictive value of 75% \[[@CR7]\].

Whether EUS elastography as virtual biopsy will in some cases replace FNA in the future remains to be established. However, it may function as a guide for selecting the most malignant-appearing lymph node for FNA, consequently reducing the number of false-negative punctures.
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